Hematologic Oncology Update cover image

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning

Hematologic Oncology Update

00:00

Community oncologists' perceptions and eligibility

Dr Lunning contrasts CAR T and transplant eligibility and recommends interim PET and MRD to identify candidates earlier.

Play episode from 13:28
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app